Sovaldi — Medical Mutual
Patient has been started on Sovaldi for an indication addressed in the Recommended Authorization Criteria
Initial criteria
- Patient has already initiated Sovaldi therapy for an approved indication
Approval duration
Remainder of course (up to total 12 or 24 weeks depending on genotype)